Immuneering Corporation (IMRX) vs LifeMD, Inc. (LFMD)
A side-by-side comparison of Immuneering Corporation and LifeMD, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IMRX
Immuneering Corporation
$3.97HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
LFMD
LifeMD, Inc.
$2.78HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — IMRX vs LFMD
growth of $100 · dividends reinvested · last 5yIMRX -77.0% (-25.5%/yr)LFMD -72.7% (-22.9%/yr)LFMD compounded faster over this window
IMRX LFMD
IMRX vs LFMD: by the numbers
- •IMRX is the larger company ($144M vs $134M market cap).
- •Both run net losses; IMRX's is the smaller (0.00% vs -10.40% net margin).
Metrics side by side
Valuation
| Metric | IMRX | LFMD |
|---|---|---|
| P/S ratio | N/A | 0.66 |
| P/B ratio | 0.75 | 16.85 |
Profitability
| Metric | IMRX | LFMD |
|---|---|---|
| Gross margin | 0.00% | 85.91% |
| Operating margin | 0.00% | -9.35% |
| Net margin | 0.00% | -10.40% |
| ROE | -30.03% | -266.86% |
| ROIC | -32.73% | -143.97% |
Growth (annualized)
| Metric | IMRX | LFMD |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 26.00% |
| Total return CAGR (5Y) | -32.77% | -14.66% |
Frequently asked
- How have IMRX and LFMD total returns compared?
- Over the past 5 years, IMRX delivered -32.77% and LFMD delivered -14.66% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Immuneering ROELifeMD ROEImmuneering operating marginLifeMD operating marginImmuneering revenue growthLifeMD revenue growthImmuneering free cash flowLifeMD free cash flow
Immuneering & LifeMD appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.